Orange Book product · Generic (ANDA)
LEVOCARNITINE
LEVOCARNITINE
At a glance
Jun 22, 2001
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 22, 2001
25 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
LEVOCARNITINE
Strength
200MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 075861
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEVOCARNITINE
- 1992CARNITORBrand (NDA)
NDA 020182 · LEADIANT BIOSCI INC
- 1988CARNITORBrand (NDA)
NDA 018948 · LEADIANT BIOSCI INC
- 1986CARNITORBrand (NDA)
NDA 019257 · LEADIANT BIOSCI INC
- 2025LEVOCARNITINEGeneric (ANDA)
ANDA 217430 · DEVA HOLDING AS
- 2022LEVOCARNITINEGeneric (ANDA)
ANDA 216384 · NOVITIUM PHARMA
- 2021LEVOCARNITINEGeneric (ANDA)
ANDA 212533 · SCIEGEN PHARMS
- 2019LEVOCARNITINEGeneric (ANDA)
ANDA 211676 · NOVITIUM PHARMA
- 2007LEVOCARNITINEGeneric (ANDA)
ANDA 077399 · HIKMA
- 2004LEVOCARNITINEGeneric (ANDA)
ANDA 076858 · RISING
- 2004LEVOCARNITINEGeneric (ANDA)
ANDA 076851 · RISING
- 2001LEVOCARNITINEGeneric (ANDA)
ANDA 075567 · HIKMA
- 2001LEVOCARNITINEGeneric (ANDA)
ANDA 075881 · TEVA PHARMS USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
